New Oral Anticoagulant Use in Renal Disease and Af (noacure-Af) Where Do We Stand? an Expert Consensus View Using the Delphi Method Reply

Turk, Ugur OnselArici, Mustafa2023-06-162023-06-1620211016-5169https://hdl.handle.net/20.500.14365/3016[Abstract Not Available]eninfo:eu-repo/semantics/closedAccessOutcomesEdoxabanImpactNew Oral Anticoagulant Use in Renal Disease and Af (noacure-Af) Where Do We Stand? an Expert Consensus View Using the Delphi Method ReplyLetter